Qualified Case Acquisition

Tepezza lawsuits have emerged, alleging that Horizon Therapeutics, the manufacturer of the drug, did not adequately warn doctors and patients about potential health risks. These legal actions primarily involve plaintiffs who have experienced permanent hearing loss or tinnitus after using Tepezza, a drug approved by the FDA in January 2020 for the treatment of thyroid eye disease (TED).

The Topamax lawsuit focuses on the alleged negligence of Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, for failing to provide adequate warning about the serious potential for birth defects in babies born to women who took Topamax while pregnant. Topamax, also known by its generic name topiramate, is a widely prescribed drug used for the treatment of epilepsy and prevention of migraine headaches.

The toxic baby food litigation is unfolding in response to alarming reports of heavy metal contamination in numerous baby food products, including pureed foods, rice cereal, and puff snacks with rice. Neurotoxic metals such as arsenic, cadmium, lead, and mercury have been found in these products, posing potential threats to the cognitive and behavioral development of children. These lawsuits primarily allege that certain baby food manufacturers have been negligent in allowing these harmful substances into their products, and failing to provide consumers with appropriate warnings about these potential health risks.

The Truvada lawsuit revolves around the alleged dangers of the popular antiviral drug. Truvada, primarily used for managing HIV infection and reducing its consequences, has been hailed as a medical breakthrough. The medication works by preventing HIV cells from multiplying, effectively preventing the progression to AIDS. Additionally, it’s also used as a pre-exposure prophylaxis (PrEP) drug, reducing the risk of HIV contraction in high-risk individuals.

In an era marked by notable strides in pharmaceutical advancements, a cloud of concern has fallen over the once widely celebrated acid reflux medication, Zantac. After the U.S Food and Drug Administration expressed concerns about the potential risk associated with the drug, a wave of lawsuits has hit the courts, with thousands of plaintiffs alleging that the drug was not only dangerous but was marketed without due warnings of the risks.